LIWANLI Innovation Co., Ltd. (TPE:3054)
Taiwan · Delayed Price · Currency is TWD 75.70
+2.50 (3.42%)
Apr 17, 2026, 1:30 PM CST
LIWANLI Innovation Market Cap
LIWANLI Innovation has a market cap or net worth of 6.11 billion as of April 17, 2026. Its market cap has increased by 239.46% in one year.
Market Cap
6.11B
Enterprise Value
5.66B
Revenue
125.54M
Ranking
n/a
PE Ratio
39.02
Stock Price
75.70
Market Cap Chart
Since April 23, 2003, LIWANLI Innovation's market cap has increased from 1.72B to 6.11B, an increase of 254.29%. That is a compound annual growth rate of 5.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 6.11B | 133.28% |
| Dec 31, 2025 | 2.62B | 31.64% |
| Dec 31, 2024 | 1.99B | 17.38% |
| Dec 29, 2023 | 1.69B | 5.26% |
| Dec 30, 2022 | 1.61B | -23.52% |
| Dec 30, 2021 | 2.10B | 5.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Handa Pharmaceuticals | 12.15B |
| Foresee Pharmaceuticals | 12.13B |
| Alar Pharmaceuticals | 11.52B |
| Standard Chemical & Pharmaceutical | 11.38B |
| Formosa Laboratories | 6.45B |
| SCI Pharmtech | 5.98B |
| Orient Pharma | 5.60B |
| Easywell Biomedicals | 5.15B |